Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS)

CUSIP: 00461U105

Q1 2021 13F Holders as of 31 Mar 2021

Holder snapshot 7 signals
Share change
+13,508,576
Put/Call ratio
64%
SEC-reported price per share
$25.20
Number of holders
95
Value change
+$509,363,836
Number of buys
64
Open additional details 1 more signal available
Number of sells
40
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
138,752,791

Security key

00461U105

Report period

Q1 2021

Institutions

95

Top holders

10

Ownership snapshot

Top reported holders of ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RENAISSANCE TECHNOLOGIES LLC
Disclosed value leader
RENAISSANCE TECHNOLOGIES LLC
Comparable rows
15/15
Latest evidence
31 Dec 2020
13F Lead comparable stake: 2.4% Showing 1-6 of 15 holder rows.

Quick read

RENAISSANCE TECHNOLOGIES LLC leads the comparable SEC ownership view at 2.4%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RENAISSANCE TECHNOLOGIES LLC's linked filing trail.
Comparable ownership Top 5
RENAISSANCE TECHNOLOGIES LLC 2.4%
Rock Springs Capital Management LP 1.9%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1.6%
Venrock Adviser, LLC 1.4%
Sofinnova Investments, Inc. 1.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
2.4%
$21,145,000
3,268,178 shares
31 Dec 2020
Rock Springs Capital Management LP
13F
Company
13F
1.9%
$17,314,000
2,676,100 shares
31 Dec 2020
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
1.6%
$14,558,000
2,250,000 shares
31 Dec 2020
Venrock Adviser, LLC
13F
Company
13F
1.4%
$12,648,000
1,954,932 shares
31 Dec 2020
Sofinnova Investments, Inc.
13F
Company
13F
1.4%
$12,368,000
1,911,573 shares
31 Dec 2020
Parkman Healthcare Partners LLC
13F
Company
13F
1.4%
$12,133,000
1,875,336 shares
31 Dec 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
95
Shares
45,417,666
Rows available
95
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders
79
Q1 2021 holders
95
Holder diff
16
Investor Q4 2020 Shares Q1 2021 Shares Share Diff Share Chg % Q4 2020 value Q1 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .